All News

2019

July

Media Release / Jul 22, 2019

Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis

Read More
Media Release / Jul 18, 2019

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read More
Media Release / Jul 09, 2019

Sandoz extends SYMJEPI™ (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine

Read More
Media Release / Jul 02, 2019

Sandoz launches oncology generic gefitinib in 13 EU countries at loss of market exclusivity, expanding access to essential medicine

Read More

June

Media Release / Jun 27, 2019

Sandoz enters agreement with Kit Check to track, automate restocking of products in U.S. hospitals

Read More
Media Release / Jun 14, 2019

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More

May

Media Release / May 15, 2019

Sandoz announces plan to improve competitiveness and realign the organization, to drive ongoing Transformation and support future growth

Read More
Media Release / May 09, 2019

Sandoz demonstrates strategic focus on China, with first-of-a-kind generic approval under Quality Consistency Evaluation system

Read More

April

Media Release / Apr 30, 2019

Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors

Read More
Media Release / Apr 24, 2019

Novartis starts 2019 with strong sales and double digit core[1] operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded

Read More